Journals in Physical sciences and engineering

Biochemical Engineering Journal

ISSN: 1369-703X
5 Year impact factor: 3.5
Impact factor: 3.7

endorsed by Division of Biochemical Engineering, The Society of Chemical Engineers, JapanBiochemical Engineering Journal welcomes submissions from NIH-funded authors. We deposit gold open access articles immediately in PubMed Central. For other articles, we shall deposit the accepted manuscript on behalf of the author to PubMed Central after 12 months (the normal embargo period for this journal is 24 months). For more information, please see here.The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics Biosensors and Biodevices including biofabrication and novel fuel cell development Bioseparations including scale-up and protein refolding/renaturation Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cellsBioreactor Systems including characterization, optimization and scale-up Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticalsBiomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis Protein Engineering including enzyme engineering and directed evolution*Authors are requested to complete a Review Proposal Form for Editorial approval prior to submission of the review article. Proposals can be submitted to [email protected] or one of the Editors.

Subscriptions

Bioelectrochemistry

ISSN: 1567-5394
5 Year impact factor: 4.5
Impact factor: 4.8

The official journal of the Bioelectrochemical Society An International Journal Devoted to Electrochemical Aspects of Biology and Biological Aspects of ElectrochemistryBioelectrochemistry is an international journal devoted to electrochemical principles in biology and biological aspects of electrochemistry. It publishes experimental and theoretical papers dealing with the electrochemical aspects of:• Electrified interfaces (electric double layers, adsorption, electron transfer, protein electrochemistry, basic principles of biosensors, biosensor interfaces and bio-nanosensor design and construction. • Electric and magnetic field effects (field-dependent processes, field interactions with molecules, intramolecular field effects, sensory systems for electric and magnetic fields, molecular and cellular mechanisms) • Bioenergetics and signal transduction (energy conversion, photosynthetic and visual membranes) • Biomembranes and model membranes (thermodynamics and mechanics, membrane transport, electroporation, fusion and insertion) • Electrochemical applications in medicine and biotechnology (drug delivery and gene transfer to cells and tissues, iontophoresis, skin electroporation, injury and repair). • Organization and use of arrays in-vitro and in-vivo, including as part of feedback control. • Electrochemical interrogation of biofilms as generated by microorganisms and tissue reaction associated with medical implants.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Biological Conservation

ISSN: 0006-3207
5 Year impact factor: 6
Impact factor: 4.9

Biological Conservation is a leading international journal in the discipline of conservation science. The journal publishes articles spanning a diverse range of fields that contribute to the biological, sociological, ethical and economic dimensions of conservation. The primary aim of Biological Conservation is the publication of high-quality papers that advance the science and practice of conservation, or which demonstrate the application of conservation principles and policy. Biological Conservation invites the submission of research articles, reviews (including systematic reviews and perspectives), short communications, policy perspectives, and letters to the editor dealing with all aspects of conservation science, including theoretical and empirical investigations into the consequences of human actions for the diversity, structure and function of terrestrial, aquatic or marine ecosystems. Such papers may include quantitative assessments of extinction risk, fragmentation effects, spread of invasive organisms, conservation genetics, conservation management, global change effects on biodiversity, landscape or reserve design and management, restoration ecology, or resource economics. We also welcome papers coming from social sciences including those reporting on advances in conservation politics, ethics, policy, human social structure and biodiversity, and political culture among other subjects. Biological Conservation covers interdisciplinary topics within conservation biology and also provides practical applications of conservation research for land/resource managers and policy makers. We publish articles and thematic special issues that have a global relevance in terms of the topics or issues addressed, and thus demonstrate applications of conservation science and management beyond the specific system or species studied. Biological Conservation is an affiliate publication of the Society for Conservation Biology (SCB). SCB members can obtain a personal subscription to this journal through the Society. Authors are also welcome to submit to the Journal's open access companion title, Global Ecology and Conservation, which covers all sub-disciplines of ecological and conservation science.

Subscriptions

Biomass & Bioenergy

ISSN: 0961-9534
5 Year impact factor: 5.2
Impact factor: 5.8

Biomass & Bioenergy is an international journal publishing original research papers and short communications, review articles and case studies on biological resources, chemical and biological processes, and biomass products for new renewable sources of energy and materials. The scope of the journal extends to the environmental, management and economic aspects of biomass and bioenergy.Key areas covered by the journal: • Biomass: sources, energy crop production processes, genetic improvements, composition. Please note that research on these biomass subjects must be linked directly to bioenergy generation. • Biological Residues: residues/rests from agricultural production, forestry and plantations (palm, sugar etc), processing industries, and municipal sources (MSW). Papers on the use of biomass residues through innovative processes/technological novelty and/or consideration of feedstock/system sustainability (or unsustainability) are welcomed. However waste treatment processes and pollution control or mitigation which are only tangentially related to bioenergy are not in the scope of the journal, as they are more suited to publications in the environmental arena. Papers that describe conventional waste streams (ie well described in existing literature) that do not empirically address 'new' added value from the process are not suitable for submission to the journal. • Bioenergy Processes: fermentations, thermochemical conversions, liquid and gaseous fuels, and petrochemical substitutes. • Bioenergy Utilization: direct combustion, gasification, electricity production, chemical processes, and by-product remediation. • Biomass and the Environment: carbon cycle, the net energy efficiency of bioenergy systems, assessment of sustainability, and biodiversity issues.The journal does not consider papers on the following subjects: • Performance of fuel combustion in engines. • Technical aspects of first generation biofuels. • Soil science papers with no direct linking to bioenergy generation. • Isolation of yeast/bacterial strains. • Purely analytical biochemistry derived studies that have no direct linking to bioenergy generation.This journal welcomes contributions that support and advance the UN's sustainable development goals, in particular SDG 7 (Affordable and clean energy) and SDG 13 (Climate Action).

Subscriptions

Biomaterials

ISSN: 0142-9612
5 Year impact factor: 13.1
Impact factor: 12.8

Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.Click here for New Editorial Instructions.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterBiomaterials is the flagship title in Elsevier's biomaterials science portfolio; it sits alongside Materials Today Bio, Biomaterials Advances and Biomaterials and Biosystems . As part of the broader Materials Today family, Biomaterials offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!

Subscriptions

Biomaterials Advances

ISSN: 0928-4931
5 Year impact factor: 5.5
Impact factor: 5.5

Formerly known as Materials Science and Engineering: C, with a 2022 IF of 7.9.Biomaterials Advances includes topics at the interface of the biomedical sciences and materials engineering. These topics include: Bioinspired and biomimetic materials for medical applicationsMaterials of biological origin for medical applicationsMaterials for "active" medical applicationsSelf-assembling and self-healing materials for medical applications"Smart" (i.e., stimulus-response) materials for medical applicationsCeramic, metallic, polymeric, and composite materials for medical applicationsMaterials for in vivo sensingMaterials for in vivo imagingMaterials for delivery of pharmacologic agents and vaccinesNovel approaches for characterizing and modeling materials for medical applicationsManuscripts on biological topics without a materials science component, or manuscripts on materials science without biological applications, will not be considered for publication in Biomaterials Advances. New submissions are first assessed for language, scope and originality (plagiarism check) and can be desk rejected before review if they need English language improvements, are out of scope or present excessive duplication with published sources.Biomaterials Advances sits within Elsevier's biomaterials science portfolio alongside Biomaterials, Materials Today Bio and Biomaterials and Biosystems. As part of the broader Materials Today family, Biomaterials Advances offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!

Subscriptions

Biomaterials Advances

ISSN: 2772-9508
5 Year impact factor: 5.5
Impact factor: 5.5

Subscriptions

Bioorganic & Medicinal Chemistry

ISSN: 0968-0896
5 Year impact factor: 3.1
Impact factor: 3.3

The Tetrahedron Journal for Research at the Interface of Chemistry and BiologyBioorganic & Medicinal Chemistry publishes complete accounts of research of outstanding significance and timeliness on all aspects of molecular interactions at the interface of chemistry and biology, together with critical review articles. The journal publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents.The Journal welcomes papers on:the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targetsthe reporting of the discovery, design or optimization of potent new compounds or biological agentsthe analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental datathe reporting of "first-in-class" new therapeutic compoundsthe chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanismmethodological advances that are chemistry-based and which significantly impact on medicine or biologythe preparation and examination of biotherapeutics for the treatment of pathophysiological disease statesthe development of materials for specific therapeutic targetingAll manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMC is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.

Subscriptions

Bioorganic & Medicinal Chemistry Letters

ISSN: 0960-894X
5 Year impact factor: 2.4
Impact factor: 2.5

BMCL (Bioorganic & Medicinal Chemistry Letters) publishes research communications of outstanding significance and timeliness on topics at the interface of chemistry and biology, together with concise review articles and perspectives. BMCL publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of BMCL is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. BMCL continues to be a major forum for the first publication of new chemical entities prior to them entering clinical trials.BMCL welcomes papers on: the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targetsThe reporting of the discovery, design or optimization of potent new compounds or biological agentsthe analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental datathe reporting of "first-in-class" new therapeutic compoundsthe chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanismmethodological advances that are chemistry-based and which significantly impact on medicine or biologythe preparation and examination of biotherapeutics for the treatment of pathophysiological disease statesthe development of materials for specific therapeutic targetingManuscripts on phytochemistry, theoretical molecular dynamics and exclusively computational papers are out of scope. All manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMCL is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.

Subscriptions

Bioorganic Chemistry

ISSN: 0045-2068
5 Year impact factor: 4.7
Impact factor: 4.5

Bioorganic Chemistry publishes research that addresses biological questions at the molecular level, using organic chemistry and principles of physical organic chemistry. The scope of the journal covers a range of topics at the organic chemistry-biology interface, including: enzyme catalysis, biotransformation and enzyme inhibition; nucleic acids chemistry; medicinal chemistry; natural product chemistry, natural product synthesis and natural product biosynthesis; antimicrobial agents; lipid and peptide chemistry; biophysical chemistry; biological probes; bio-orthogonal chemistry and biomimetic chemistry.For manuscripts dealing with synthetic bioactive compounds, the Journal requires that the molecular target of the compounds described must be known, and must be demonstrated experimentally in the manuscript. For studies involving natural products, if the molecular target is unknown, some data beyond simple cell-based toxicity studies to provide insight into the mechanism of action is required. Studies supported by molecular docking are welcome, but must be supported by experimental data. The Journal does not consider manuscripts that are purely theoretical or computational in nature.The Journal publishes regular articles, short communications and reviews. Reviews are normally invited by Editors or Editorial Board members. Authors of unsolicited reviews should first contact an Editor or Editorial Board member to determine whether the proposed article is within the scope of the Journal.Benefits to authors We also provide many author benefits, such as a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Related subjects

Astronomy astrophysics space science

Built environment

Chemical engineering

Chemistry

Computer science

Earth and planetary sciences

Energy and power

Engineering and technology

Environmental sciences

Materials science

Mathematics

Physics

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Physical sciences and engineering

Biochemical Engineering Journal

Bioelectrochemistry

Biological Conservation

Biomass & Bioenergy

Biomaterials

Biomaterials Advances

Biomaterials Advances

Bioorganic & Medicinal Chemistry

Bioorganic & Medicinal Chemistry Letters

Bioorganic Chemistry

Related subjects